Innocoll Holdings plc Announces Closing of Public Offering
June 22, 2016 16:30 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, June 22, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a specialty pharmaceutical and medical device company with late stage development programs targeting areas...
Innocoll Holdings plc Announces Pricing of Public Offering of Ordinary Shares
June 16, 2016 22:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, June 16, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs...
Innocoll Holdings plc to Present at the JMP Securities Life Sciences Conference
June 16, 2016 09:20 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, June 16, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll Holdings plc Announces Proposed Public Offering of Ordinary Shares
June 13, 2016 16:15 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, June 13, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll Holdings plc Announces First Quarter 2016 Financial and Operating Results and Provides Corporate Update
May 31, 2016 16:05 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, May 31, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll Announces XARACOLL® (bupivacaine-collagen bioresorbable implant) Meets Primary Endpoint in Both Pivotal Phase 3 Trials in Postoperative Pain Relief
May 25, 2016 07:30 ET
|
Innocoll Holdings plc
First long-acting, opioid-sparing, local analgesic to meet primary endpoints of Phase 3 clinical trials in hernia repairData supports on-schedule NDA filing this yearResults validate the Innocoll...
Innocoll to Host Live Webcast on Top-Line Results from Two Pivotal Phase 3 Trials of XARACOLL® (bupivacaine-collagen bioresorbable implant) in Postoperative Pain Relief
May 24, 2016 16:15 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, May 24, 2016 (GLOBE NEWSWIRE) -- Innocoll (NASDAQ:INNL), a global, commercial-stage, specialty pharmaceutical company, today announced that the Company will host a live webcast...
Innocoll to Report First Quarter 2016 Financial Results and Host Webcast and Conference Call on May 31, 2016
May 18, 2016 16:10 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, May 18, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of...
Innocoll Holdings plc Appoints Lesley Russell, MBChB, MRCP, as Chief Medical Officer
April 20, 2016 16:43 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, April 20, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll Holdings plc Announces Fourth Quarter and Full-Year 2015 Financial and Operating Results and Provides Corporate Update
March 17, 2016 08:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, March 17, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...